Intraventricular Hemorrhage and Patent Ductus Arteriosus Ligation Association with Infant Mortality

Robert J McLoughlin1, Brittany M Dacier2, Max D Hazeltine1

  • 1Department of Surgery, University of Massachusetts Medical School, Worcester, Massachusetts.

Insights

Premature infants undergoing patent ductus arteriosus (PDA) ligation face higher mortality if they also have intraventricular hemorrhage (IVH). High-grade IVH (grades III or IV) significantly increases this risk, indicating a need for careful management strategies.

Area of Science:

  • Neonatal Medicine
  • Pediatric Surgery
  • Clinical Outcomes Research

Background:

  • Management of patent ductus arteriosus (PDA) in premature infants is evolving.
  • Intraventricular hemorrhage (IVH) is a common complication in premature neonates.
  • The impact of PDA ligation on mortality in premature infants with IVH requires further investigation.

Purpose of the Study:

  • To assess the association between PDA ligation and mortality in premature infants with co-existing intraventricular hemorrhage (IVH).
  • To identify specific IVH grades that contribute to increased mortality risk following PDA ligation.

Main Methods:

  • Utilized the Kids' Inpatient Database (KID) from 2006, 2009, and 2012.
  • Identified premature neonates (gestational age ≤36 weeks) with IVH diagnosis.
  • Analyzed PDA ligation procedures and outcomes using ICD-9 codes, case weighting, and multivariable logistic regression.

Main Results:

  • 7567 hospitalizations for premature neonates undergoing PDA ligation were identified.
  • Infants with IVH had increased mortality (10.7% vs. 6.3%) and longer hospital stays compared to those without IVH.
  • High-grade IVH (grades III or IV) was significantly associated with increased in-hospital mortality risk (aOR 2.59 for any IVH, aOR 1.99 for grade III, aOR 3.16 for grade IV).

Conclusions:

  • Premature neonates with high-grade IVH (grades III or IV) undergoing PDA ligation face a significantly elevated risk of mortality.
  • These findings underscore the critical need to consider IVH severity when managing PDA in vulnerable premature infants.
  • Current practice patterns for PDA management should account for the heightened mortality risk in the presence of severe IVH.
Abstract